Advanced Glycation End Products Impair Cardiac Atrial Appendage Stem Cells Properties

Background: During myocardial infarction (MI), billions of cardiomyocytes are lost. The optimal therapy should effectively replace damaged cardiomyocytes, possibly with stem cells able to engraft and differentiate into adult functional cardiomyocytes. As such, cardiac atrial appendage stem cells (CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Evens, Lize, Heeren, Ellen, Rummens, Jean-Luc, Bronckaers, Annelies, Hendrikx, Marc, Deluyker, Dorien, Bito, Virginie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269351/
https://www.ncbi.nlm.nih.gov/pubmed/34279448
http://dx.doi.org/10.3390/jcm10132964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269351/
https://www.ncbi.nlm.nih.gov/pubmed/34279448
http://dx.doi.org/10.3390/jcm10132964

Ejemplares similares